Gerrit Dispersyn - 01 Mar 2022 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
President & CEO, Director
Signature
Caitlin Kontulis, attorney-in-fact
Issuer symbol
PHIO
Transactions as of
01 Mar 2022
Net transactions value
-$7,351
Form type
4
Filing time
03 Mar 2022, 18:12:51 UTC
Previous filing
16 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Tax liability $7,351 -8,954 -4% $0.8210 212,327 01 Mar 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold.
F2 Includes shares of common stock underlying unvested restricted stock units.